D
Transphorm, Inc.
TGAN
$4.80
-$0.01-0.21%
D
Sell
1/11/2024Upgraded
Transphorm, Inc. (TGAN) was upgraded to D- from E+ on 1/11/2024 due to an increase in the volatility index.
Transphorm, Inc. (TGAN) was upgraded to D- from E+ on 1/11/2024 due to an increase in the volatility index.
E
Sell
4/4/2023Downgrade
Transphorm, Inc. (TGAN) was downgraded to E+ from D- on 4/4/2023 due to a decline in the total return index and volatility index.
Transphorm, Inc. (TGAN) was downgraded to E+ from D- on 4/4/2023 due to a decline in the total return index and volatility index.
D
Sell
3/14/2023Downgrade
Transphorm, Inc. (TGAN) was downgraded to D- from D on 3/14/2023 due to a large decline in the total return index, solvency index and growth index. EBIT declined 79.9% from -$5.5M to -$9.9M, operating cash flow declined 78.96% from -$4.9M to -$8.77M, and earnings per share declined from -$0.1059 to -$0.1844.
Transphorm, Inc. (TGAN) was downgraded to D- from D on 3/14/2023 due to a large decline in the total return index, solvency index and growth index. EBIT declined 79.9% from -$5.5M to -$9.9M, operating cash flow declined 78.96% from -$4.9M to -$8.77M, and earnings per share declined from -$0.1059 to -$0.1844.
D
Sell
2/9/2023Upgraded
Transphorm, Inc. (TGAN) was upgraded to D from E+ on 2/9/2023 due to an increase in the volatility index.
Transphorm, Inc. (TGAN) was upgraded to D from E+ on 2/9/2023 due to an increase in the volatility index.
E
Sell
2/8/2023Downgrade
Transphorm, Inc. (TGAN) was downgraded to E+ from D on 2/8/2023 due to a noticeable decline in the solvency index, total return index and volatility index. The quick ratio declined from 2.43 to 1.87, and debt to equity increased from 0.3 to 0.34.
Transphorm, Inc. (TGAN) was downgraded to E+ from D on 2/8/2023 due to a noticeable decline in the solvency index, total return index and volatility index. The quick ratio declined from 2.43 to 1.87, and debt to equity increased from 0.3 to 0.34.
D
Sell
5/16/2022Upgraded
Transphorm, Inc. (TGAN) was upgraded to D from E+ on 05/16/2022.
Transphorm, Inc. (TGAN) was upgraded to D from E+ on 05/16/2022.
E
Sell
5/13/2022Downgrade
Transphorm, Inc. (TGAN) was downgraded to E+ from D on 5/13/2022 due to a decline in the total return index.
Transphorm, Inc. (TGAN) was downgraded to E+ from D on 5/13/2022 due to a decline in the total return index.
D
Sell
5/4/2022Upgraded
Transphorm, Inc. (TGAN) was upgraded to D from E+ on 05/04/2022.
Transphorm, Inc. (TGAN) was upgraded to D from E+ on 05/04/2022.
E
Sell
5/1/2022Downgrade
Transphorm, Inc. (TGAN) was downgraded to E+ from D on 5/1/2022 due to a decline in the total return index.
Transphorm, Inc. (TGAN) was downgraded to E+ from D on 5/1/2022 due to a decline in the total return index.
D
Sell
4/21/2022Upgraded
Transphorm, Inc. (TGAN) was upgraded to D from E+ on 4/21/2022 due to an increase in the total return index.
Transphorm, Inc. (TGAN) was upgraded to D from E+ on 4/21/2022 due to an increase in the total return index.
E
Sell
4/20/2022Downgrade
Transphorm, Inc. (TGAN) was downgraded to E+ from D on 4/20/2022 due to a major decline in the growth index and valuation index. EBIT declined 221.2% from $3.93M to -$4.77M, earnings per share declined from $0.14 to -$0.0847, and total revenue declined 59.27% from $11.3M to $4.6M.
Transphorm, Inc. (TGAN) was downgraded to E+ from D on 4/20/2022 due to a major decline in the growth index and valuation index. EBIT declined 221.2% from $3.93M to -$4.77M, earnings per share declined from $0.14 to -$0.0847, and total revenue declined 59.27% from $11.3M to $4.6M.
D
Sell
11/18/2021Upgraded
Transphorm, Inc. (TGAN) was upgraded to D from D- on 11/18/2021 due to a major increase in the growth index, total return index and volatility index. Total revenue increased 251.46% from $3.22M to $11.3M, EBIT increased 185.45% from -$4.6M to $3.93M, and earnings per share increased from -$0.1735 to $0.14.
Transphorm, Inc. (TGAN) was upgraded to D from D- on 11/18/2021 due to a major increase in the growth index, total return index and volatility index. Total revenue increased 251.46% from $3.22M to $11.3M, EBIT increased 185.45% from -$4.6M to $3.93M, and earnings per share increased from -$0.1735 to $0.14.
D
Sell
11/3/2021Downgrade
Transphorm, Inc. (TGAN) was downgraded to D- from D on 11/3/2021 due to a decline in the volatility index.
Transphorm, Inc. (TGAN) was downgraded to D- from D on 11/3/2021 due to a decline in the volatility index.
D
Sell
10/8/2021Upgraded
Transphorm, Inc. (TGAN) was upgraded to D from D- on 10/8/2021 due to an increase in the volatility index and total return index.
Transphorm, Inc. (TGAN) was upgraded to D from D- on 10/8/2021 due to an increase in the volatility index and total return index.
D
Sell
8/18/2021Downgrade
Transphorm, Inc. (TGAN) was downgraded to D- from D on 8/18/2021 due to a decline in the growth index, total return index and solvency index. The quick ratio declined from 0.41 to 0.3, debt to equity increased from -1.45 to -1.2, and EBIT declined 1.43% from -$4.54M to -$4.6M.
Transphorm, Inc. (TGAN) was downgraded to D- from D on 8/18/2021 due to a decline in the growth index, total return index and solvency index. The quick ratio declined from 0.41 to 0.3, debt to equity increased from -1.45 to -1.2, and EBIT declined 1.43% from -$4.54M to -$4.6M.
D
Sell
8/2/2021Upgraded
Transphorm, Inc. (TGAN) was upgraded to D from D- on 8/2/2021 due to an increase in the valuation index.
Transphorm, Inc. (TGAN) was upgraded to D from D- on 8/2/2021 due to an increase in the valuation index.
D
Sell
4/1/2021Upgraded
Transphorm, Inc. (TGAN) was upgraded to D- from E on 4/1/2021 due to a major increase in the total return index, volatility index and growth index. Operating cash flow increased 55.3% from -$3.18M to -$1.42M, total revenue increased 4.35% from $1.93M to $2.01M, and earnings per share increased from -$0.1917 to -$0.1904.
Transphorm, Inc. (TGAN) was upgraded to D- from E on 4/1/2021 due to a major increase in the total return index, volatility index and growth index. Operating cash flow increased 55.3% from -$3.18M to -$1.42M, total revenue increased 4.35% from $1.93M to $2.01M, and earnings per share increased from -$0.1917 to -$0.1904.
E
Sell
1/4/2021Upgraded
Transphorm, Inc. (TGAN) was upgraded to E from E- on 1/4/2021 due to an increase in the total return index and solvency index.
Transphorm, Inc. (TGAN) was upgraded to E from E- on 1/4/2021 due to an increase in the total return index and solvency index.
E
Sell
10/21/2020None
Transphorm, Inc. (TGAN) was downgraded to E- from U on 10/21/2020.
Transphorm, Inc. (TGAN) was downgraded to E- from U on 10/21/2020.
NASDAQ
04/17/2024 4:00PM Eastern
Quotes delayed
